Phenominer Database Results (21 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj blood glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. blood glucose amount male 210 days 16 126.8 mg/dl 2.7 10.8 oral glucose tolerance test tail gastric gavage 90 min Arkray, Kyoto, Japan 13214 230
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj serum total cholesterol level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood cholesterol amount male 218 days 7 65.8 mg/dl 2.93 7.75 serum total cholesterol measurement test 0 0 Wako Pure Chemicals, Tokyo, Japan 12787 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj epididymal fat pad weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. epididymal fat pad mass male 218 days 7 5.5 g 0.5 1.32 post excision weight measurement 0 12790 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj blood glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. blood glucose amount male 210 days 16 127.0 mg/dl 3.2 12.8 oral glucose tolerance test tail gastric gavage 30 min Arkray, Kyoto, Japan 13212 230
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj serum triglyceride level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood triglyceride amount male 218 days 7 89.9 mg/dl 6.73 17.81 serum triglyceride analysis 0 0 Wako Pure Chemicals, Tokyo, Japan 13193 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj mesenteric fat pad weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. mesenteric fat pad mass male 218 days 7 4.4 g 0.7 1.85 post excision weight measurement 0 12788 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj body weight fasting (for 16 hours) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. body mass male 210 days 16 366.8 g 4.2 16.8 body weighing method 0 11985 230
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj mesenteric fat pad weight to body weight ratio specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. mesenteric fat pad mass male 218 days 7 1.18 % 0.15 0.4 post excision weight measurement 0.0 0 67468 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 7 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67476 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj serum adiponectin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood adiponectin amount male 211 days 7 3.03 ng/ml 0.23 0.61 enzyme linked immunosorbent assay 0.0 0 ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67480 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj serum leptin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood leptin amount male 211 days 7 2.8 ng/ml 0.54 1.43 enzyme linked immunosorbent assay 0.0 oral glucose 7 days ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67484 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj serum free fatty acids level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood free fatty acid amount male 218 days 7 0.75 mmol/l 0.05 0.14 serum free fatty acid analysis 0.0 0 Wako Pure Chemicals, Tokyo, Japan 67496 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj blood glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. blood glucose amount male 210 days 16 88.8 mg/dl 1.4 5.6 oral glucose tolerance test tail gastric gavage 0 min Arkray, Kyoto, Japan 13211 230
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj epididymal fat pad weight to body weight ratio specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. epididymal fat pad mass male 218 days 7 1.48 % 0.12 0.32 post excision weight measurement 0.0 0 67492 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj blood glucose level area under curve (AUC) fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. blood glucose amount male 210 days 16 14626.9 (mg/dl) x min 209.1 836.4 oral glucose tolerance test tail 0.0 gastric gavage 0 Arkray, Kyoto, Japan 67779 230
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj blood glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. blood glucose amount male 210 days 16 127.1 mg/dl 3.5 14.0 oral glucose tolerance test tail gastric gavage 60 min Arkray, Kyoto, Japan 13213 230
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj body weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. body mass male 211 days 7 368.7 g 8.7 23.02 body weighing method oral glucose 0 min 12791 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj retroperitoneal fat pad weight to body weight ratio specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. retroperitoneal fat pad mass male 218 days 7 1.48 % 0.13 0.34 post excision weight measurement 0.0 0 67472 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj blood glucose level fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. blood glucose amount male 210 days 16 124.8 mg/dl 2.6 10.4 oral glucose tolerance test tail gastric gavage 120 min Arkray, Kyoto, Japan 13215 230
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj blood glucose level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood glucose amount male 211 days 7 78.7 mg/dl 3.4 9.0 oral glucose tolerance test 0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 12786 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj retroperitoneal fat pad weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. retroperitoneal fat pad mass male 218 days 7 5.5 g 0.5 1.32 post excision weight measurement 0 12789 311